Nikolas K. Haass

7.9k total citations
99 papers, 4.3k citations indexed

About

Nikolas K. Haass is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Nikolas K. Haass has authored 99 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 38 papers in Oncology and 27 papers in Cell Biology. Recurrent topics in Nikolas K. Haass's work include Melanoma and MAPK Pathways (28 papers), Cancer Cells and Metastasis (20 papers) and Cellular Mechanics and Interactions (12 papers). Nikolas K. Haass is often cited by papers focused on Melanoma and MAPK Pathways (28 papers), Cancer Cells and Metastasis (20 papers) and Cellular Mechanics and Interactions (12 papers). Nikolas K. Haass collaborates with scholars based in Australia, United States and Germany. Nikolas K. Haass's co-authors include Meenhard Herlyn, Keiran S.M. Smalley, Patricia Brafford, Keith T. Flaherty, Mercedes Lioni, Kimberley A. Beaumont, Farzana Ahmed, Johanna M. Brandner, Nethia Mohana‐Kumaran and Rooha Contractor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Nikolas K. Haass

97 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikolas K. Haass Australia 36 2.8k 1.7k 822 579 572 99 4.3k
Amaya Virós United Kingdom 21 2.1k 0.8× 1.6k 0.9× 625 0.8× 496 0.9× 459 0.8× 46 3.3k
Richard M. Neve United States 29 2.8k 1.0× 2.3k 1.4× 651 0.8× 761 1.3× 400 0.7× 53 4.7k
Patricia Brafford United States 18 2.6k 0.9× 1.4k 0.9× 561 0.7× 756 1.3× 505 0.9× 24 3.5k
Claudia Wellbrock United Kingdom 32 4.0k 1.4× 2.2k 1.3× 1.2k 1.4× 627 1.1× 1.1k 2.0× 57 5.6k
Luigi Strizzi United States 36 3.1k 1.1× 2.2k 1.3× 604 0.7× 711 1.2× 368 0.6× 85 5.1k
Sara Sigismund Italy 27 3.9k 1.4× 1.3k 0.8× 2.0k 2.5× 535 0.9× 693 1.2× 38 5.9k
Jinyan Du United States 26 4.2k 1.5× 2.1k 1.2× 1.6k 1.9× 1.0k 1.8× 1.0k 1.8× 37 6.3k
Victoria Sanz‐Moreno United Kingdom 35 2.7k 1.0× 1.6k 1.0× 1.6k 2.0× 762 1.3× 548 1.0× 63 4.7k
Haiyong Han United States 44 4.8k 1.7× 2.1k 1.3× 719 0.9× 1.1k 1.9× 572 1.0× 114 7.1k
Monilola A. Olayioye Germany 33 3.2k 1.1× 2.5k 1.5× 760 0.9× 595 1.0× 377 0.7× 72 5.1k

Countries citing papers authored by Nikolas K. Haass

Since Specialization
Citations

This map shows the geographic impact of Nikolas K. Haass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolas K. Haass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolas K. Haass more than expected).

Fields of papers citing papers by Nikolas K. Haass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolas K. Haass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolas K. Haass. The network helps show where Nikolas K. Haass may publish in the future.

Co-authorship network of co-authors of Nikolas K. Haass

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolas K. Haass. A scholar is included among the top collaborators of Nikolas K. Haass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolas K. Haass. Nikolas K. Haass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malekan, Mohammad, et al.. (2024). VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives. Life Sciences. 345. 122563–122563. 22 indexed citations
2.
Leo, Paul, Sudha Rao, Sarju Vasani, et al.. (2023). Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges. British Journal of Cancer. 128(10). 1807–1818. 10 indexed citations
3.
Murphy, Ryan J., Alexander P. Browning, Gency Gunasingh, Nikolas K. Haass, & Matthew J. Simpson. (2022). Designing and interpreting 4D tumour spheroid experiments. Communications Biology. 5(1). 91–91. 23 indexed citations
4.
Fane, Mitchell E., Yash Chhabra, Loredana Spoerri, et al.. (2021). Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion. Journal of Investigative Dermatology. 142(7). 1845–1857. 3 indexed citations
5.
Cruz, Jazmina L. Gonzalez, Bijun Zeng, Muhammed B. Sabdia, et al.. (2021). Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers. 13(15). 3733–3733. 13 indexed citations
6.
Beaumont, Kimberley A., Danae M. Sharp, Goldie Y.L. Lui, et al.. (2020). Abrogation of RAB27A expression transiently affects melanoma cell proliferation. Pigment Cell & Melanoma Research. 33(6). 889–894. 6 indexed citations
7.
Vittadello, Sean T., Scott W. McCue, Gency Gunasingh, Nikolas K. Haass, & Matthew J. Simpson. (2020). Examining Go-or-Grow Using Fluorescent Cell-Cycle Indicators and Cell-Cycle-Inhibiting Drugs. Biophysical Journal. 118(6). 1243–1247. 20 indexed citations
8.
Oo, Zay Yar, Alexander J. Stevenson, Sebastian Walpole, et al.. (2018). Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo. Clinical Cancer Research. 24(12). 2901–2912. 17 indexed citations
9.
Hammerlindl, Heinz, Dinoop Ravindran Menon, Abdullah Al Emran, et al.. (2017). Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS -Mutant Cancers. Clinical Cancer Research. 24(5). 1090–1102. 15 indexed citations
10.
Chauvistré, Heike, Oliver Keminer, Andrea Sechi, et al.. (2017). Enforced polarization of melanoma cells towards a JARID1B-high phenotype exhausts tumour fitness. RWTH Publications (RWTH Aachen). 15. 4–4.
11.
Kienzle, Arne, et al.. (2016). Real-time cell cycle and cell death imaging of the effect of sphingosine kinase inhibition on 3D melanoma spheroids. Experimental Dermatology. 25(3). 1 indexed citations
12.
Mohana‐Kumaran, Nethia, Xu Dong Zhang, Peter Hersey, et al.. (2011). Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737. Clinical Cancer Research. 18(3). 783–795. 92 indexed citations
13.
Haass, Nikolas K., et al.. (2009). Genetics of basal cell carcinoma. Australasian Journal of Dermatology. 51(2). 81–92. 48 indexed citations
14.
Santiago-Walker, Ademi, et al.. (2009). Melanocytes: From Morphology to Application. Skin Pharmacology and Physiology. 22(2). 114–121. 56 indexed citations
15.
Haass, Nikolas K., Katrin Sproesser, Thiennga K. Nguyen, et al.. (2008). The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel. Clinical Cancer Research. 14(1). 230–239. 185 indexed citations
16.
Haass, Nikolas K.. (2008). From Xiphophorus to Melanoma—A Tribute to Steven Kazianis (1966–2008). Zebrafish. 5(2). 91–92. 2 indexed citations
17.
Smalley, Keiran S.M., Rooha Contractor, Nikolas K. Haass, et al.. (2007). An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells. Cancer Research. 67(1). 209–217. 176 indexed citations
18.
Smalley, Keiran S.M., Rooha Contractor, Nikolas K. Haass, et al.. (2007). Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels. British Journal of Cancer. 96(3). 445–449. 69 indexed citations
19.
Smalley, Keiran S.M., Nikolas K. Haass, Patricia Brafford, et al.. (2006). Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Molecular Cancer Therapeutics. 5(5). 1136–1144. 370 indexed citations
20.
Haass, Nikolas K., Johanna M. Brandner, Patricia Brafford, et al.. (2004). Differential expression of connexins in melanoma and adjacent epidermis. Cancer Research. 64. 639–639. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amaya Virós Breakdown of academic impact, for papers by Richard M. Neve Breakdown of academic impact, for papers by Patricia Brafford Breakdown of academic impact, for papers by Claudia Wellbrock Breakdown of academic impact, for papers by Luigi Strizzi Breakdown of academic impact, for papers by Sara Sigismund Breakdown of academic impact, for papers by Jinyan Du Breakdown of academic impact, for papers by Victoria Sanz‐Moreno Breakdown of academic impact, for papers by Haiyong Han Breakdown of academic impact, for papers by Monilola A. Olayioye
Rankless by CCL
2026